- Treatment of hypothyroidsm
-
Jo YS, Shong M
- KMID: 1984654
- Korean J Med.
- 2005 Jul;69(1):119-120.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Identification of Growth Regulatory Factors in Medullary Thyroid Carcinoma Cell Line
-
Jo YS, Shong M
- KMID: 1468501
- J Korean Endocr Soc.
- 2009 Jun;24(2):84-86.
- doi: 10.3803/jkes.2009.24.2.84
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Epigenetic Regulation of RUNX3 in Thyroid Carcinoma
-
Joung KH, Shong M
- KMID: 2432929
- Korean J Intern Med.
- 2012 Dec;27(4):391-393.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Postoperative Findings of the Cytological Diagnosis of Follicular Neoplasm or Hurthle Cell Neoplasm and Risk of Malignancy
-
Lee JU, Shong M
- KMID: 1497753
- Endocrinol Metab.
- 2010 Dec;25(4):298-300.
- doi: 10.3803/EnM.2010.25.4.298
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Pathogenetic Mechanisms and Therapeutic Implications of BRAFV600E in Papillary Thyroid Cancer
-
Shong M, Jo YS, Ro HK
- KMID: 2063532
- J Korean Endocr Soc.
- 2007 Aug;22(4):245-251.
- doi: 10.3803/jkes.2007.22.4.245
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Response: GDF15 Is a Novel Biomarker for Impaired Fasting Glucose (Diabetes Metab J 2014;38:472-9)
-
Hong JH, Ku BJ, Shong M
- KMID: 2280662
- Diabetes Metab J.
- 2015 Feb;39(1):84-86.
- doi: 10.4093/dmj.2015.39.1.84
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Follicular and Hurthle cell carcinoma of the thyroid in iodine-sufficient area: retrospective analysis of Korean multicenter data
-
Kim WG, Kim TY, Kim TH, Jang HW, Jo YS, Park YJ, Kim SW, Kim WB, Shong M, Park DJ, Chung JH, Shong YK, Cho BY
- KMID: 1792058
- Korean J Intern Med.
- 2014 May;29(3):325-333.
- doi: 10.3904/kjim.2014.29.3.325
BACKGROUND/AIMS: Follicular thyroid carcinoma (FTC) and Hurthle cell carcinoma (HCC) of the thyroid are relatively uncommon thyroid malignancies in iodine-sufficient areas. In this study we evaluated the clinical behavior, prognostic... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Multiple Endocrine Neoplasia Type I with Atypical Clinical Course
-
Choi YS, Bai YS, Ku BJ, Jo YS, Kim YK, Ro HK, Shong M
- KMID: 2333264
- J Korean Endocr Soc.
- 2008 Aug;23(4):266-271.
Multiple endocrine neoplasia type 1 (MEN 1) is characterized by the combined occurrence of primary hyperparathyroidism, enteropancreatic tumors and anterior pituitary adenoma. Yet carcinoid tumors, adrenal adenoma and lipoma might... -
- CITED
-
- Close
- SHARE
-
- Close
- Two Cases of Simple Virilizing Congenital Adrenal Hyperplasia with Compound Heterozygous Mutations of CYP21 Gene
-
Kim KS, Choi YS, Bai YS, Rha SY, Jo YS, Shong M
- KMID: 2063542
- J Korean Endocr Soc.
- 2007 Aug;22(4):299-304.
- doi: 10.3803/jkes.2007.22.4.299
Steroid 21-hydroxylase deficiency is the most frequent cause of congenital adrenal hyperplasia (CAH), which is an inherited inability to synthesize cortisol. Actually, CAH is caused by mutations in the CYP21... -
- CITED
-
- Close
- SHARE
-
- Close
- The Role of Growth Differentiation Factor 15 in Energy Metabolism
-
Chang JY, Hong HJ, Kang SG, Kim JT, Zhang BY, Shong M
- KMID: 2512994
- Diabetes Metab J.
- 2020 Jun;44(3):363-371.
- doi: 10.4093/dmj.2020.0087
Growth differentiation factor 15 (GDF15) is receiving great interest beyond its role as an aging and disease-related biomarker. Recent discovery of its receptor, glial cell line-derived neurotrophic factor (GDNF) family... -
- CITED
-
- Close
- SHARE
-
- Close
- Protocol for a Korean Multicenter Prospective Cohort Study of Active Surveillance or Surgery (KoMPASS) in Papillary Thyroid Microcarcinoma
-
Jeon MJ, Kang YE, Moon JH, Lim DJ, Lee CY, Lee YS, Kim SW, Kim MH, Kim BH, Kang HC, Shong M, Cho SW, Kim WB
- KMID: 2527150
- Endocrinol Metab.
- 2022 Feb;37(1):181-182.
- doi: 10.3803/EnM.2022.104
-
- CITED
-
- Close
- SHARE
-
- Close
- Development of Metabolic Synthetic Lethality and Its Implications for Thyroid Cancer
-
Ju SH, Lee SE, Kang YE, Shong M
- KMID: 2527136
- Endocrinol Metab.
- 2022 Feb;37(1):53-61.
- doi: 10.3803/EnM.2022.1402
Cancer therapies targeting genetic alterations are a topic of great interest in the field of thyroid cancer, which frequently harbors mutations in the RAS, RAF, and RET genes. Unfortunately, U.S.... -
- CITED
-
- Close
- SHARE
-
- Close
- Oncogenes, mitochondrial metabolism, and quality control in differentiated thyroid cancer
-
Yi HS, Chang JY, Kim KS, Shong M
- KMID: 2411478
- Korean J Intern Med.
- 2017 Sep;32(5):780-789.
- doi: 10.3904/kjim.2016.420
Thyroid cancer is one of the most common malignancies of endocrine organs, and its incidence rate has increased steadily over the past several decades. Most differentiated thyroid tumors derived from... -
- CITED
-
- Close
- SHARE
-
- Close
- Metabolic Reprogramming in Thyroid Cancer
-
Ju SH, Song M, Lim JY, Kang YE, Yi HS, Shong M
- KMID: 2556634
- Endocrinol Metab.
- 2024 Jun;39(3):425-444.
- doi: 10.3803/EnM.2023.1802
Thyroid cancer is a common endocrine malignancy with increasing incidence globally. Although most cases can be treated effectively, some cases are more aggressive and have a higher risk of mortality.... -
- CITED
-
- Close
- SHARE
-
- Close
- Cellular and Intercellular Homeostasis in Adipose Tissue with Mitochondria-Specific Stress
-
Choi MJ, Jung SB, Chang JY, Shong M
- KMID: 2513282
- Endocrinol Metab.
- 2021 Feb;36(1):1-11.
- doi: 10.3803/EnM.2021.956
Paracrine interactions are imperative for the maintenance of adipose tissue intercellular homeostasis, and intracellular organelle dysfunction results in local and systemic alterations in metabolic homeostasis. It is currently accepted that... -
- CITED
-
- Close
- SHARE
-
- Close
- Mitochondrial Energy Metabolism and Thyroid Cancers
-
Lee J, Chang JY, Kang YE, Yi S, Lee MH, Joung KH, Kim KS, Shong M
- KMID: 2282001
- Endocrinol Metab.
- 2015 Jun;30(2):117-123.
- doi: 10.3803/EnM.2015.30.2.117
Primary thyroid cancers including papillary, follicular, poorly differentiated, and anaplastic carcinomas show substantial differences in biological and clinical behaviors. Even in the same pathological type, there is wide variability in... -
- CITED
-
- Close
- SHARE
-
- Close
- Regulation of Systemic Glucose Homeostasis by T Helper Type 2 Cytokines
-
Kang YE, Kim HJ, Shong M
- KMID: 2460948
- Diabetes Metab J.
- 2019 Oct;43(5):549-559.
- doi: 10.4093/dmj.2019.0157
Obesity results in an inflammatory microenvironment in adipose tissue, leading to the deterioration of tissue protective mechanisms. Although recent studies suggested the importance of type 2 immunity in an anti-inflammatory... -
- CITED
-
- Close
- SHARE
-
- Close
- Expression of miRNA 146a/b, 221 and 222 in Thyroid Cancer
-
Jo YS, Lee IS, Hong W, Song IS, Shong M, Kim JR
- KMID: 1468491
- J Korean Endocr Soc.
- 2009 Mar;24(1):17-24.
- doi: 10.3803/jkes.2009.24.1.17
BACKGROUND: miRNAs can be diagnostic markers and therapeutic targets in cancers, but few studies have been conducted in thyroid cancer. We investigated the expression levels of miRNA 146a/b, 221, and... -
- CITED
-
- Close
- SHARE
-
- Close
- Mitochondrial Stress and Mitokines: Therapeutic Perspectives for the Treatment of Metabolic Diseases
-
Zhang B, Chang JY, Lee MH, Ju SH, Yi HS, Shong M
- KMID: 2551258
- Diabetes Metab J.
- 2024 Jan;48(1):1-18.
- doi: 10.4093/dmj.2023.0115
Mitochondrial stress and the dysregulated mitochondrial unfolded protein response (UPRmt) are linked to various diseases, including metabolic disorders, neurodegenerative diseases, and cancer. Mitokines, signaling molecules released by mitochondrial stress response... -
- CITED
-
- Close
- SHARE
-
- Close
- Association between DIO2 Thr92Ala polymorphism and hypertension in patients with hypothyroidism: Korean Genome and Epidemiology Study
-
Kang YM, Koo BS, Yi HS, Kim JT, Park B, Lee JH, Shong M, Kang YE
- KMID: 2539975
- Korean J Intern Med.
- 2023 Mar;38(2):226-237.
- doi: 10.3904/kjim.2022.292
Background/Aims: Recent evidence has identified the significance of type 2 iodothyronine deiodinase (DIO2) in various diseases. However, the role of DIO2 polymorphism in metabolic parameters in patients with hypothyroidism is... -
- CITED
-
- Close
- SHARE
-
- Close
